Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/24/2012EP2513093A1 New ccr2 receptor antagonists and uses thereof
10/24/2012EP2513092A1 Heterocyclic antiviral compounds
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513089A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/24/2012EP2513088A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513087A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators
10/24/2012EP2513086A1 Novel antagonists for ccr2 and uses thereof
10/24/2012EP2513085A1 BICYCLIC COMPOUNDS AS alpha4beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
10/24/2012EP2513084A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513071A1 Thiazole derivatives for treating diseases such as cancer
10/24/2012EP2513070A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012EP2513068A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
10/24/2012EP2513066A1 Sphingosine kinase inhibitors
10/24/2012EP2513064A2 Compounds, compositions and methods for controlling biofilms
10/24/2012EP2513062A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
10/24/2012EP2513061A1 Pyridone derivatives as nk3 antagonists
10/24/2012EP2513060A1 Alpha-crystalline form of carbabenzpyride
10/24/2012EP2513058A1 Methods of synthesizing factor xa inhibitors
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2513051A1 Combretastatin derivatives and uses therefor
10/24/2012EP2513042A2 Solid dapoxetine
10/24/2012EP2512581A1 Implantable device with intravesical tolerability and methods of treatment
10/24/2012EP2512517A2 Hyperbranched polyester having a hydrophobic core for solubilizing active ingredients of low solubility
10/24/2012EP2512504A1 Treatment composition and method
10/24/2012EP2512497A1 Methods and compositions related to clot-binding compounds
10/24/2012EP2512491A1 Hbv antisense inhibitors
10/24/2012EP2512490A1 S-adenosylmethionine formulations with enhanced bioavailability
10/24/2012EP2512489A1 Formulations of acadesine
10/24/2012EP2512488A1 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails
10/24/2012EP2512487A2 Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
10/24/2012EP2512486A1 Nestorone®/estradiol transdermal gel
10/24/2012EP2512485A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance
10/24/2012EP2512484A1 Methods for the treatment of speech impediments
10/24/2012EP2512483A2 Balaglitazone compositions and methods
10/24/2012EP2512481A2 Hair growth and / or regrowth compositions
10/24/2012EP2512480A1 Hepatitis c virus inhibitors
10/24/2012EP2512479A1 Methods and compositions for treating peripheral vascular disease
10/24/2012EP2512478A1 Homogeneous suspension of immunopotentiating compounds and uses thereof
10/24/2012EP2512477A1 Hcv combination therapy
10/24/2012EP2512476A1 Method for treating haematological cancers
10/24/2012EP2512475A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases
10/24/2012EP2512474A1 N-linked hydroxamic acid derivatives useful as antibacterial agents
10/24/2012EP2512473A1 Tumour treatment agents and method
10/24/2012EP2512472A1 Therapeutic combinations of theobromine and an antihistamine
10/24/2012EP2512471A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
10/24/2012EP2512470A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
10/24/2012EP2512469A1 3-(indolyl)-or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma
10/24/2012EP2512468A1 METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS
10/24/2012EP2512467A1 Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012EP2512465A1 Use of compounds in the treatment or prevention of skin disorders
10/24/2012EP2512464A1 Combination of theobromine with a decongestant and its use for the treatment of cough
10/24/2012EP2512463A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail
10/24/2012EP2512462A1 Multifunctional zwitterionic polymer conjugates
10/24/2012EP2512461A1 Chalcones as enhancer of antimicrobial agents
10/24/2012EP2512459A2 Therapeutic polymeric nanoparticles comprising epothilone and methods of making and using same
10/24/2012EP2512458A1 Low toxicity topical active agent delivery system
10/24/2012EP2512456A2 Abuse-resistant formulations
10/24/2012EP2512451A1 Modulator
10/24/2012EP2512448A2 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
10/24/2012EP2512447A1 Antifungal composition intended to be applied to a perforated nail
10/24/2012EP2512446A1 Composition of dexibuprofen transdermal hydrogel
10/24/2012EP2512445A1 Suppository comprising pantoprazole
10/24/2012EP2512440A1 Orodispersible tablet, containing dapoxetine
10/24/2012EP2512439A1 Antibiotic microparticles for inhalation
10/24/2012EP2512267A1 Coffee treatment method
10/24/2012EP2512250A1 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/24/2012EP2512247A1 Novel thiophene inhibitors of s-nitrosoglutathione reductase
10/24/2012EP2512246A1 Aminopyrimidines as syk inhibitors
10/24/2012EP2512245A1 Pyridoquinazolinone m1 receptor positive allosteric modulators
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012EP2512242A1 Novel compounds
10/24/2012EP2512241A1 Compounds for the treatment of neurologic disorders
10/24/2012EP2512240A1 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
10/24/2012EP2512239A1 Bridged bicyclic rho kinase inhibitor compounds, composition and use
10/24/2012EP2512238A1 Fused tricyclic compounds for the treatment of inflammatory disorders
10/24/2012EP2512236A1 Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
10/24/2012EP2512231A1 Composition in form of a gel for the virucidal disinfection of mammalian skin
10/24/2012EP2512230A1 Non-irritating ophthalmic povidone-iodine compositions
10/24/2012DE202007019460U1 Kristalline Tigecyclin-Formen Crystalline forms of tigecycline
10/24/2012CN102753678A Bacterial strains having an outstanding ability to produce menaquinone
10/24/2012CN102753565A Progesterone receptor antagonists
10/24/2012CN102753564A 6-substituted estradiol derivatives and methods of use
10/24/2012CN102753563A Nucleoside analogs
10/24/2012CN102753562A Mannose derivatives as antagonists of bacterial adhesion
10/24/2012CN102753559A Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
10/24/2012CN102753558A Nitroimidazooxazines and their uses in anti-tubercular therapy
10/24/2012CN102753557A Salt of fused heterocyclic derivative and crystal thereof
10/24/2012CN102753554A Raf inhibitor compounds and methods of use thereof
10/24/2012CN102753553A 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
10/24/2012CN102753552A Novel benzoic pyrrolopyridine derivatives
10/24/2012CN102753551A 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753550A Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753549A Compounds and methods for kinase modulation, and indications therefor
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
10/24/2012CN102753547A 三唑并吡啶衍生物 Triazole and pyridine derivatives
10/24/2012CN102753546A A novel 5-membered heterocycle derivatives and manufacturing process thereo
10/24/2012CN102753545A Oxadiazole derivative having endothelial lipase inhibitory activity
1 ... 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 ... 7860